Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload
暂无分享,去创建一个
Jing Liu | Guiping Yang | Yoshihiro Ishikawa | S. Vatner | S. Okumura | J. Kawabe | Y. Ishikawa | D. Vatner | J. Sadoshima | C. Hong | Guiping Yang | Satoshi Okumura | Gen Takagi | Junichi Sadoshima | Stephen F Vatner | Jun-ichi Kawabe | Ming-Chih Lee | Chull Hong | Dorothy E Vatner | Jing Liu | G. Takagi | Ming-Chih Lee
[1] S. Vatner,et al. β-Adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic Gsα mouse , 1999 .
[2] M Feinleib,et al. Role of blood pressure in the development of congestive heart failure. The Framingham study. , 1972, The New England journal of medicine.
[3] S. Vatner,et al. Downregulation of adenylylcyclase types V and VI mRNA levels in pacing-induced heart failure in dogs. , 1994, The Journal of clinical investigation.
[4] M. Raynolds,et al. Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice. , 2000, Journal of molecular and cellular cardiology.
[5] M. Gao,et al. Adenylyl Cyclase Increases Survival in Cardiomyopathy , 2002, Circulation.
[6] J. Cohn,et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.
[7] L. Boxer,et al. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis , 1996, Molecular and cellular biology.
[8] W. Colucci,et al. p38 Mitogen-activated Protein Kinase Pathway Protects Adult Rat Ventricular Myocytes against β-Adrenergic Receptor-stimulated Apoptosis , 2000, The Journal of Biological Chemistry.
[9] T. Anzai,et al. Adenylylcyclase increases responsiveness to catecholamine stimulation in transgenic mice. , 1999, Circulation.
[10] S. Madersbacher,et al. A low‐molecular‐weight fraction of human seminal plasma activates adenylyl cyclase and induces caspase 3‐independent apoptosis in prostatic epithelial cells by decreasing mitochondrial potential and Bcl‐2/Bax ratio , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] S. Vatner,et al. Adverse Effects of Chronic Endogenous Sympathetic Drive Induced by Cardiac Gsα Overexpression , 1996 .
[12] S. Vatner,et al. Cardiomyopathy induced by cardiac Gs alpha overexpression. , 1997, The American journal of physiology.
[13] E. Olson,et al. Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure. , 1999, Circulation research.
[14] J. Hanoune,et al. Enhanced cardiac function in transgenic mice expressing a Ca(2+)-stimulated adenylyl cyclase. , 2000, Circulation research.
[15] Y. Ishikawa,et al. The adenylyl cyclases as integrators of transmembrane signal transduction. , 1997, Circulation research.
[16] K. Adams,et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. , 1996, Circulation.
[17] M. Lohse,et al. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[18] E. Olson,et al. Dilated Cardiomyopathy and Sudden Death Resulting From Constitutive Activation of Protein Kinase A , 2001, Circulation research.
[19] R. Virmani,et al. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[20] S. Vatner,et al. Is treating cardiac hypertrophy salutary or detrimental: the two faces of Janus. , 2003, American journal of physiology. Heart and circulatory physiology.
[21] S. Vatner,et al. beta-adrenergic receptor signaling: an acute compensatory adjustment-inappropriate for the chronic stress of heart failure? Insights from Gsalpha overexpression and other genetically engineered animal models. , 2000, Circulation research.
[22] M. Gao,et al. Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy. , 1999, Circulation.
[23] B. Kobilka,et al. Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] A. Dart,et al. beta(2)-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis. , 2000, Circulation.
[25] G. Dorn,et al. Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling. , 1999, Biochemistry.
[26] S. Korsmeyer,et al. Involvement of Microtubules in the Regulation of Bcl2 Phosphorylation and Apoptosis through Cyclic AMP-Dependent Protein Kinase , 1998, Molecular and Cellular Biology.
[27] G. Dorn,et al. Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. , 2000, Circulation.
[28] J. Hanoune,et al. Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase. , 2000, American journal of physiology. Renal physiology.
[29] J. Hanoune,et al. Type V, but not type VI, adenylyl cyclase mRNA accumulates in the rat heart during ontogenic development. Correlation with increased global adenylyl cyclase activity. , 1995, Journal of molecular and cellular cardiology.
[30] J. Hoerter,et al. Augmentation of cardiac contractility with no change in L‐type Ca2+ current in transgenic mice with a cardiac‐directed expression of the human adenylyl cyclase type 8 (AC8) , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] S. Liggett,et al. Transgenic replacement of type V adenylyl cyclase identifies a critical mechanism of β‐adrenergic receptor dysfunction in the Gαq overexpressing mouse , 1999 .
[32] Y. Ishikawa,et al. Changes in type VI adenylyl cyclase isoform expression correlate with a decreased capacity for cAMP generation in the aging ventricle. , 1994, Circulation research.
[33] S. Vatner,et al. Beta-adrenergic receptor-G protein-adenylyl cyclase signal transduction in the failing heart. , 1999, The American journal of cardiology.